Visit other SMART + STRONG sites:
AIDSMEDSREAL HEALTHTU SALUD
Subscribe to:
POZ magazine
E-newsletters
POZ Personals
Sign In / Join
Username:
Password:

Back to home » News » January 2008

Web Exclusives

Pomp, Circumstance and a Second Chance

The Low Down on the Down Low

Negotiating a Fair Price for the Norvir Tablet

» More

Most Talked About

(Un)deniable Evidence: A college professor takes on AIDS naysayers in his latest book (36)

Mom Imprisoned for Posting HIV Patient’s Medical Info Online (29)

New California Budget Slashes $55.5 Million From AIDS Funds (24)

CVS Criticized for Condom Lockup in Communities of Color (21)

Negotiating a Fair Price for the Norvir Tablet (13)

POZ Twitter Updates
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

10 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

January 24, 2008

Factors Influencing Regimen Choice Shifting for Positive Women

Women living with HIV are increasingly basing which drugs to take as part of their antiretroviral regimens on social or demographic factors as opposed to biological ones, Aidsmap reports (aidsmap.com, 1/23).

A report published in the January 15 edition of Clinical Infectious Diseases followed 2,700 American HIV-positive women over a ten-year span, broken up into three periods: 1996 to 2000, 2000 to 2002, and 2002 to 2005.

From 1996 to 2002, CD4 count was the major determining factor in choosing which meds to take. Women with a CD4 count higher than 200 were more than twice as likely as women whose count was lower than 200 to start a non-nucleoside reverse transcriptase inhibitor (NNRTI) regimen than a protease inhibitor (PI) regimen. However, from 2002 through 2005, demographic factors appeared to play a role in initial regimen choice—black and Latina women, for example, were more likely to initiate a regimen with a PI than a (NNRTI).


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]

Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Watch Videos
Read the Blogs
Visit the Forums
Women's Hub
African American Hub
Latino Hub
Community Hub
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    AugustReignn
    Washington
    DC


    paperheart12
    Orlando
    Florida


    PozCub77
    North Hollywood
    California


    kokonutz1962
    Henderson
    Kentucky
Click here to join POZ Personals!
Talk to Us
Poll
Question: Do you believe that treatment as prevention places too much responsibility for the general public's health on people living with HIV?
Yes
No

Survey
How is your overall health?

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy